First Hawaiian Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-975
Closed -$320K – 168
2024
Q4
$320K Hold
975
– – 0.01% 739
2024
Q3
$326K Sell
975
-17
-2% -$5.4K 0.01% 731
2024
Q2
$271K Sell
992
-1,010
-50% -$294K 0.01% 712
2024
Q1
$692K Sell
2,002
-46
-2% -$15.1K 0.02% 509
2023
Q4
$661K Sell
2,048
-23
-1% -$7.21K 0.02% 512
2023
Q3
$742K Hold
2,071
– – 0.03% 458
2023
Q2
$785K Buy
2,071
+1,297
+168% +$528K 0.03% 456
2023
Q1
$371K Buy
+774
New +$362K 0.01% 673
2020
Q3
– Sell
-816
Closed -$368K – 791
2020
Q2
$368K Sell
816
-161
-16% -$71K 0.02% 513
2020
Q1
$342K Sell
977
-16
-2% -$5.88K 0.02% 482
2019
Q4
$367K Sell
993
-337
-25% -$119K 0.02% 602
2019
Q3
$442K Buy
1,330
+316
+31% +$103K 0.02% 498
2019
Q2
$317K Sell
1,014
-429
-30% -$128K 0.02% 624
2019
Q1
$441K Sell
1,443
-240
-14% -$64.8K 0.02% 491
2018
Q4
$391K Sell
1,683
-596
-26% -$160K 0.02% 487
2018
Q3
$713K Buy
+2,279
New +$707K 0.04% 366

Other funds holding BIO

First Hawaiian Bank's BIO Position: Q1 2025 in Review

First Hawaiian Bank sold out of Bio-Rad Laboratories Class A (BIO) in Q1 2025, closing a stake of 975 shares — an estimated $320K sold.

First Hawaiian Bank first reported a position in BIO in Q3 2018 and held it in 16 quarters. The position peaked at $785K in Q2 2023. 436 funds tracked by Wall St. Rank hold BIO as of Q1 2025.

  • First Hawaiian Bank reported no remaining Bio-Rad Laboratories Class A position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 975 Bio-Rad Laboratories Class A shares in Q1 2025, an estimated $320K.
  • First Hawaiian Bank first reported a position in Bio-Rad Laboratories Class A in Q3 2018 and held it in 16 quarters.
  • First Hawaiian Bank's Bio-Rad Laboratories Class A position peaked at $785K in Q2 2023.
  • 436 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.